제품 세부정보
Source
Monoclonal Anti-Mumps virus Fusion glycoprotein F0 Antibody, Human IgG1 (8F8) is a chimeric monoclonal antibody recombinantly expressed in HEK293, which combines the variable region of a mouse monoclonal antibody with human constant domain.
Antibody Type
Recombinant Monoclonal
Clone
8F8
Isotype
Human IgG1, Kappa
Host Species
Mouse
Reactivity
Mumps virus (strain Miyahara vaccine) (MuV)
Immunogen
Recombinant Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0 is expressed from human 293 cells
Specificity
Specifically recognizes Mumps virus Fusion glycoprotein F0 Protein.
Purification
Protein A purified / Protein G purified.
Aggregation
Less than 10%, as determined by SEC-MALS.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
Bioactivity-ELISA

Immobilized Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Mumps virus Fusion glycoprotein F0 Antibody, Human IgG1 (8F8) (Cat. No. RSF-MY2093) with a linear range of 0.06-2 ng/mL (QC tested).
Protocol
사용자 리뷰 댓글 남기기

배경 소개
프론티어 진행
- 영어 이름:
Respiratory syncytial virus F protein
- 카테고리:
- 상장 의약품 수:
3 상세
- 임상 의약품 수:
7 상세
- 최고 개발 단계:
Approved
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521



















